We reiterate Buy (High Risk) on Oscar Health with a $44 price target, viewing the stock as a levered call option on the durability of the American Affordable Act, ACA marketplace architecture and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback